Xtant Medical Inc. (XTNT)
0.50
0.01 (2.17%)
At close: Mar 31, 2025, 12:27 PM
Xtant Medical Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | 117.27M | 91.3M | 57.97M | 55.26M | 53.34M | 64.68M | 72.2M | 82.61M | 90M | 59.35M | 35.33M | 33.07M | 32.98M | 30.15M | 15.42M | 7.39M | 459.23K |
| Cost of Revenue | 49.05M | 35.84M | 25.83M | 22.77M | 18.95M | 22.17M | 28.72M | 32.51M | 27.71M | 20.26M | 13.03M | 14.19M | 10.34M | 9.11M | 3.36M | 2.32M | 386.48K |
| Gross Profit | 68.22M | 55.47M | 32.14M | 32.49M | 34.39M | 42.52M | 43.49M | 50.1M | 62.29M | 39.08M | 22.3M | 18.89M | 22.64M | 21.04M | 12.05M | 5.08M | 72.75K |
| Operating Income | -12.07M | -10.16M | -6.75M | -3.85M | -751K | -2.35M | -60.08M | -37.83M | -7.55M | -12.08M | -6.26M | -9.01M | -4.94M | -6.45M | -8.61M | -3.62M | -15.85K |
| Interest Income | n/a | 149K | 31K | 995K | 5.98M | 5.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.04K | 12.99K | n/a |
| Pretax Income | -16.26M | -1.04M | -8.42M | -4.85M | -6.73M | -8.12M | -70.1M | -52.41M | -19.44M | -19.71M | -10.51M | -12.69M | -7.71M | -3.01M | -19.47M | -4.13M | -15.85K |
| Net Income | -16.45M | 660K | -8.48M | -5.84M | -7.02M | -8.22M | -70.1M | -52.41M | -19.49M | -2.17M | -10.51M | -12.69M | -7.71M | -3.01M | -19.47M | -4.13M | -15.85K |
| Selling & General & Admin | 77.91M | 64.29M | 37.98M | 35.47M | 34.49M | 43.78M | 45.06M | 55.84M | 60.09M | 41.97M | 25.93M | 26.79M | 27.18M | 26.74M | 20.03M | 4.16M | 88.59K |
| Research & Development | 2.38M | 1.34M | 915K | 870K | 657K | 932K | 1.7M | 2.44M | 3.41M | 2.55M | 1.44M | 572.36K | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | 58K | 3K | -74.71K | -351.91K | 388.18K | -318.84K | 92.64K | -1.56M | 755.39K | 633.83K | 72.3K | 88.59K |
| Operating Expenses | 80.29M | 65.63M | 38.89M | 36.34M | 35.14M | 44.77M | 50.88M | 63.77M | 68.44M | 48.34M | 27.65M | 27.17M | 27.59M | 27.49M | 20.67M | 8.7M | 88.59K |
| Interest Expense | 4.16M | 2.94M | 1.69M | 995K | 5.98M | 5.77M | 10.14M | 14.7M | 12.26M | 7.73M | 5.66M | 4.65M | 1.86M | 1.16M | 1.65M | 513.93K | n/a |
| Selling & Marketing Expenses | 49.21M | 38.44M | 22.52M | 21.02M | 20.98M | 25.84M | 32.06M | 40.51M | 44.06M | 28.73M | 16.91M | 16.02M | 15.62M | 18.5M | 8.9M | n/a | n/a |
| Cost & Expenses | 129.34M | 101.46M | 64.72M | 59.12M | 54.09M | 66.94M | 79.6M | 96.28M | 96.15M | 68.6M | 40.68M | 41.35M | 37.92M | 36.6M | 24.03M | 11.02M | 475.07K |
| Income Tax | 187K | -1.7M | 69K | 995K | 296K | 98K | 124K | 14.63M | 50.36K | -17.54M | 5.34M | 4.75M | 306.26K | 1.16M | 1.65M | 1.83K | n/a |
| Shares Outstanding (Basic) | 133.67M | 119.09M | 94.09M | 85.46M | 28.5M | 13.16M | 11.74M | 1.51M | 1.06M | 829.71K | 545.55K | 435.49K | 388.91K | 356.83K | 294.83K | 242.4K | 242.4K |
| Shares Outstanding (Diluted) | 133.67M | 126.79M | 94.09M | 85.46M | 28.5M | 13.16M | 11.83M | 1.52M | 1.06M | 829.71K | 545.55K | 435.49K | 388.91K | 356.83K | 294.83K | 242.4K | 242.4K |
| EPS (Basic) | -0.12 | 0.01 | -0.09 | -0.07 | -0.25 | -0.62 | -5.97 | -34.76 | -18.46 | -2.62 | -19.26 | -29.15 | -19.83 | -8.43 | -66.03 | -17.02 | -0.07 |
| EPS (Diluted) | -0.12 | 0.01 | -0.09 | -0.07 | -0.25 | -0.62 | -5.93 | -34.51 | -18.32 | -2.62 | -19.26 | -29.15 | -19.83 | -8.43 | -66.03 | -17.02 | -0.07 |
| EBITDA | -12.07M | 5.07M | -5.43M | -2.51M | 1.33M | 850K | -54.22M | -29.31M | 61.43K | -7.09M | -3.9M | -7.29M | -5.07M | -1.09M | -17.14M | -2.9M | -15.85K |
| Depreciation & Amortization | n/a | 3.17M | 1.3M | 1.34M | 2.1M | 3.2M | 5.74M | 8.39M | 7.24M | 4.89M | 952.32K | 377.52K | 782.89K | 755.39K | 682.54K | 707.93K | n/a |